Summary:We demonstrate the usefulness of pegylated liposomal doxorubicin (PL-doxorubicin) combine with CD20 antibody Rituximab in a case of transformation of anaplastic large cell lymphoma (ALCL) to high-grade diffuse large B-cell lymphoma (B-DLCL).Case report:A 63-year-old woman suffering from ...
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology Author links open overlay panelDavid W. Scott 1, 2, Rebecca L. King 3, Annette M. Staiger 4, 5, Susana Ben-Neriah 1, Aixiang Jiang 6, Heike Horn 5, Anja Mottok ...
摘要: A HHV-8 producing immortalized lymphoma cell line, which is free of EBV, CMV, and HIV, and which produces large quantities of uncontaminated HHV-8.收藏 引用 批量引用 报错 分享 文库来源 求助全文 HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV 优质文献 ...
DIFFUSE large B-cell lymphomasPEMBROLIZUMABLYMPHOMASTHERAPEUTICSBackground: Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) is standard first‐line therapy diffuse large B‐cell lymphoma (DLBCL). The anti‐PD‐1 antibody pembrolizumab (P) shows limited efficacy in relapsed...
Background: MYC rearrangements occur approximately in 5-15% of diffuse large B-cell lymphoma (DLBCL), and are known to unfavorably impact on patients (pts) survival, especially if associated to BCL2 or/and BCL6 rearrangements (double/triple-hit). Previous studies have shown that also a MYC ...
Background: High-grade B-cell lymphoma with c-MYC and BCL2 and/or BCL6 rearrangements (HGBL-DHL/THL) is a recently identified category in the most recent World Health Organization (WHO) classification. For all tumors displaying the appearance of diffuse
diffuse large B cell lymphoma; extracellular vesicles; cancer; diagnostic; liquid biopsy; plasma1. Introduction B-cell lymphomas develop from abnormal B-lymphocytes and account for 85% of all non-Hodgkin’s lymphomas (NHLs). Diffuse large B-cell lymphoma (DLBCL) is the most common form of ...
and the better monitoring of long-term classical Hodgkin lymphoma and diffuse large B-cell lymphoma survivors on late cardiological sequelae. The research focused on patients treated in adulthood and with first- or second-line antineoplastic therapies, including autologous stem cell transplant. Our pu...
Unfavorable prognostic impact of MYC increased copy number (ICN) in patients with diffuse large B-cell (DLBCL) and high-grade lymphoma treated with immunoc... Aims: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with various genetic alterations. The aim was to investigate MYC...
Primary High-Grade Large Cell Type Gastric Lymphoma - eleven years survival and follow-up.Dnyanesh M. BelekarVinayak. V. DewoolkarInternet Scientific Publications